DaShenLin Pharmaceutical Group Co. Ltd Financials

Market Capitalization CN¥19.50 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	19.91
Forward PE	13.92
Price to Sales TTM	CN¥0.73
Price to Book MRQ	CN¥2.65
Enterprise to Revenue	0.75
Enterprise to EBITDA	6.18

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	3.66%
Operating Margin	9.96%
Return on Assets TTM	3.86%
Return on Equity TTM	11.98%

Income Statement

Revenue TTM	CN¥26,700,625,920
Revenue per Share TTM	CN¥23.58
Quarterly Revenue Growth	3.00%
Gross Profit TTM	CN¥9,113,180,160
EBITDA	CN¥1,546,295,165
Net Income to Common TTM	CN¥976,302,720
Diluted EPS TTM	CN¥0.86
Quarterly Earnings Growth YoY	15.40%

Balance Sheet

Total Cash MRQ	CN¥6,737,785,344
Total Cash per Share MRQ	CN¥5.92
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	79.16
Current Ratio MRQ	0.97
Book Value per Share MRQ	CN¥6.46

Cash Flow

Operating Cash Flow TTM	CN¥3,647,646,208
Levered Free Cash Flow TTM	CN¥2,589,583,616

603233 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	1,138,847,895
Float Shares	393,369,451
Avg 10 Volume	6,336,044
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	67.36%
% Held by Institutions	9.56%

Stock Price Summary

Beta	0.49
Fifty Two Week Low	CN¥11.92
Fifty Two Week High	CN¥19.00
Fifty Two Week Change	19.02%
Day 50 MA	CN¥17.31
Day 200 MA	CN¥15.73

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.24
Forward Annual Dividend Yield	7.39%
Trailing Annual Dividend Rate	CN¥0.31
Trailing Annual Dividend Yield	1.85%
Payout Ratio	72.09%
Dividend Date
Ex Dividend Date	2025-06-19
Last Split Factor
Last Split Date	2023-06-09